The "superiority" of enoxaparin for treatment of acute coronary syndromes

被引：2
|
作者：
Noviasky, JA
Gaffney, BJ
机构：
[1] St Elizabeth Hosp, Dept Pharm Serv, Utica, NY 13501 USA
[2] Mohawk Valley Heart Inst, Cardiac Catheterizat Lab, Utica, NY USA
来源：
PHARMACOTHERAPY | 2001年 / 21卷 / 10期
关键词：
D O I：
10.1592/phco.21.15.1250.33892
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1250 / 1252
页数：3
相关论文
共 50 条
  • [1] Superiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes
    Cohen, M
    Antman, EM
    [J]. PHARMACOTHERAPY, 2002, 22 (04): : 542 - 550
  • [2] Enoxaparin in acute coronary syndromes: Evidence for superiority over placebo or untreated control
    Massel, D
    Cruickshank, MK
    [J]. AMERICAN HEART JOURNAL, 2002, 143 (05) : 748 - 752
  • [3] Enoxaparin in acute coronary syndromes
    Lee, Sinjin
    Gibson, C. Michael
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2007, 5 (03) : 387 - 399
  • [4] Enoxaparin for acute coronary syndromes?
    Pechlaner, C
    Gritsch, W
    Wiedermann, C
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) : 2007 - 2007
  • [5] Comparison of fondaparinux and enoxaparin in acute coronary syndromes
    Yusuf, S
    Mehta, SR
    Bassand, JP
    Budaj, A
    Chrolavicius, S
    Fox, KAA
    Granger, CB
    Joyner, C
    Peters, RJG
    Wallentin, L
    Avezum, A
    Boden, W
    Cardona, E
    Ceremuzynski, L
    Col, J
    Commerford, PJ
    Diaz, R
    Faxon, D
    Flather, M
    Fodor, G
    Franzosi, MG
    Granger, C
    Halon, D
    Hunt, D
    Karatzas, N
    Keltai, M
    Kenda, M
    Kim, JH
    Lanas, F
    Lau, CP
    Lewis, BS
    Morais, J
    Moccetti, T
    Pais, P
    Paolasso, E
    Parkhomenko, A
    Petrauskiene, B
    Piegas, L
    Pipilis, A
    Robaayah, D
    Ruda, M
    Rumboldt, Z
    Rupprecht, HJ
    Sitkei, E
    Steg, PG
    Swahn, E
    Theroux, P
    Valentin, V
    Varigos, J
    Weitz, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14): : 1464 - 1476
  • [6] Fondaparinux versus enoxaparin in acute coronary syndromes
    Majure, DT
    Aberegg, SK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26): : 2829 - 2829
  • [7] Pharmacokinetic study of Enoxaparin in patients undergoing coronary intervention after treatment with subcutaneous enoxaparin in acute coronary syndromes: The PEPCI study
    Martin, JL
    Fry, ET
    Sanderink, G
    Atherley, T
    Ozoux, ML
    Guimart, C
    Chevalier, P
    Pensyl, C
    Serano, A
    Bigonzi, F
    Sydney, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 10G - 11G
  • [8] Fondaparinux versus enoxaparin in acute coronary syndromes - Reply
    Yusuf, S
    Granger, CB
    Mehta, SR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26): : 2830 - 2830
  • [9] Combination therapy with tirofiban and enoxaparin in acute coronary syndromes
    Cohen, M
    Théroux, P
    Weber, S
    Laramée, P
    Huynh, T
    Borzak, S
    Diodati, JG
    Squire, IB
    Deckelbaum, LI
    Thornton, AR
    Harris, KE
    Sax, FL
    Lo, MW
    White, HD
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 71 (03) : 273 - 281
  • [10] Pharmacokinetic study of enoxaparin in patients undergoing coronary intervention after treatment with subcutaneous enoxaparin in acute coronary syndromes. The PEPCI study
    Martin, JL
    Fry, ETA
    Serano, A
    Atherley, TH
    Ozoux, ML
    Guimart, C
    Chevalier, P
    Bigonzi, F
    Pensyl, C
    Sanderink, GJ
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 : 14 - 14
12345